
The United Kingdom’s Home Affairs Committee is recommending the government widen access to unlicensed cannabis-based products for medical use via the National Health Service before the end of the current Parliament. The National Health Service (NHS) is England’s publicly funded health care system. The government has two months to respond to the committee’s recommendation. There are currently no licensed cannabis-based products for medical use (CBPMs) in the U.K. And, though unlicensed CBPMs may be prescribed, none have received marketing authorization.… Read more.